EX-99.1 2 tm2332252d1_ex99-1.htm EXHIBIT 99.1

 

Exhibit 99.1

 

Amended Loan Schedule to Secured Promissory Note dated November 10, 2022
between Acura Pharmaceuticals, Inc. and Abuse Deterrent Pharma, LLC
       
  Date Principal Aggregated Principal
       
  Original Secured Promissory Note 11/10/2022 $2,319,279 $2,319,279
  Additional loans to be included:      
               Loan #1 12/22/2022 $250,000 $2,569,279
               Loan #2 1/19/2023 $250,000 $2,819,279
               Loan #3 2/22/2023 $250,000 $3,069,279
               Loan #4 3/20/2023 $250,000 $3,319,279
               Loan #5 5/19/2023 $150,000 $3,469,279
               Loan #6 7/10/2023 $200,000 $3,669,279
               Loan #7 7/28/2023 $250,000 $3,919,279
               Loan #8 8/30/2023 $250,000 $4,169,279
               Loan #9 10/11/2023 $250,000 $4,419,279
               Loan #10 12/04/2023 $250,000 $4,669,279

 

 

 

ACURA PHARMACEUTICALS, INC.

 

By: /s/ Peter A. Clemens

Peter A. Clemens

Senior Vice President & Chief Financial Officer

 

Date: December 4, 2023